At A Glance
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in the United Kingdom, Canada, Germany, and Singapore. Its global headquarters is located at the Cambridge Science Park in Cambridge, England.
Mundipharma (Bangladesh) Pvt. Ltd is a 100% foreign equity company registered with the Board of Investment, Bangladesh. It has a state-of-art manufacturing plant spread over an area of 10000 sq. mt in Gazipur. The manufacturing plant has world-class production and quality assurance facilities complying with Mundipharma global standards. It produces the world-famous Betadine Antiseptic Range of formulations as well as long-acting formulation tablets with a patented drug delivery system called as the CONTINUS technology.
The medical fraternity, across the length and breadth of Bangladesh, perceives Mundipharma Bangladesh Pvt. Ltd. as a pharma company offering top-quality products produced with the latest technology like CONTINUS Technology. Our 3 well-established brands incorporating the patented CONTINUS Technology are Nitrocontin®, TRD – Contin®, and Unicontin®.
The biggest name of trust from Mundipharma is the topical microbicide Betadine®. In 75 countries, Betadine® is trusted for its uncompromising antiseptic efficacy. Currently, Mundipharma Bangladesh offers solutions in Antisepsis, Angina Management, Pain Management, Hepatoprotection and Laxatives. It is shortly introducing a range of nutritional supplements by the name of Nusowin.
The company services the doctors of Bangladesh through two sales and marketing teams, one operating in acute care therapy and the other in chronic care therapy covering all 64 districts of Bangladesh.
Mundipharma (Bangladesh) Pvt. Ltd. Envisions to be a leading player in the pharmaceutical space in Bangladesh and create a name for itself in Doctor – Patient support through its products and services
Where Journey Started
The pharmaceutical operations had started in the year 1982 with Win-Medicare in collaboration with Sterling Drugs of USA in India. In 1989, Sterling Drug was sold to Eastman Kodak in the USA and this relationship came to an end.
Post this, Umesh Modi group based in Delhi, India became a licensee of Mundipharma, a global (ex-US) network of independent associated companies that research, develop, and manufacture innovative pharmaceutical medicines and consumer healthcare products for selling Betadine® range of products in India.
The association with Mundipharma was later spun off into a 50:50 JV arrangement between Mundipharma Group and Mr. Umesh K. Modi of the Umesh Modi Group of Industries, a leading business conglomerate in India.
Modi-Mundipharma group, through collaborations with global players, is into the gamut of healthcare business including Pharmaceuticals, Cosmetics, Nutrition, Phytopharmaceuticals & Consumer Health.
Mundipharma Bangladesh is one of the business ventures of Umesh Modi Group of Industries. Mundipharma Bangladesh manufacturing facility in Bangladesh is situated in Gazipur & Headquartered at Gulshan 1 in Dhaka.
In-Licensing Agreements
Zambon (Italy)
Sigma-Tau (Italy)
Norgine (Netherlands)
Lavipharm (Greece)
